Summary — HB 5370
Title: AN ACT PROHIBITING CERTAIN TREATMENT PRACTICES AND PROMOTING PSYCHOTHERAPY FOR MINORS EXPERIENCING GENDER DYSPHORIA OR INCONGRUENCE
Subject: Gender identity or expression; Health care providers
Introduced: March 14, 2025 (filed); Legislative actions through May 15, 2025
Main purpose / intent
Based on the bill title, HB 5370 seeks to (1) prohibit specified medical interventions for minors who are diagnosed with or present as having gender dysphoria or gender incongruence and (2) encourage or require psychotherapy or counseling approaches as the primary or preferred treatment for these minors. The stated aim would be to limit certain medical or surgical gender‑affirming interventions for youth and to promote mental‑health‑focused care.
Key provisions (as indicated by title)
The bill text is not provided here. The title and legislative history indicate the bill would likely include:
- A prohibition on one or more categories of medical treatments for minors with gender dysphoria/incongruence (commonly these bills target puberty‑suppressing medications, cross‑sex hormones, and certain surgical interventions).
- Requirements or incentives to provide psychotherapy, counseling, or other mental‑health services for minors experiencing gender dysphoria/incongruence as an alternative or prerequisite to medical interventions.
- Provisions that affect how health care providers counsel, refer, or deliver care to these minors (possible record‑keeping, informed‑consent, or parental‑notification components).
- Possible interaction with insurance coverage, minor‑consent laws, and professional licensing/discipline for providers who violate prohibitions.
Because the bill text is not attached, specific definitions, prohibited procedures, exceptions (e.g., medical necessity), enforcement mechanisms, and penalties are not available here.
Who would be affected
- Minors (persons under the age defined in the bill) experiencing gender dysphoria or incongruence.
- Health care providers who diagnose or treat gender dysphoria (pediatricians, endocrinologists, mental‑health professionals, surgeons).
- Families and parents/guardians of minors seeking gender‑affirming care.
- Health insurers and public programs if coverage exclusions or mandates are included.
- Schools and other child‑serving institutions could be indirectly affected if the bill addresses referrals or care coordination.
Procedural history / timeline (selected)
- 2025-01-16: Referred to Joint Committee on Public Health
- 2025-03-14: Filed
- April 2025: Public hearing (4/22); committee considered and later reported favorably (4/28)
- May 7–14, 2025: Committee report distributed; considered by Calendars; amended (5/14)
- May 15, 2025: Read 3rd time; passed; reported engrossed; received from the House (record votes and statements recorded in journal)
Note: Legislative records show the bill was amended and passed on May 15, 2025. Confirm whether “passed” means passage in one chamber only, final enactment, or sent to the other chamber for concurrence and review the official legislative site for final disposition.
Impact considerations
- If enacted, the bill could restrict access to certain gender‑affirming medical interventions for minors and shift clinical practice toward psychotherapy‑centered approaches.
- Potential legal, medical‑ethics, and insurance implications — including litigation risk, changes in provider practice standards, and impacts on continuity of care for transgender and gender‑diverse youths.
- Fiscal impacts would depend on any mandates, enforcement mechanisms, and effects on health‑care utilization; fiscal notes should be consulted.
Limitations / next steps
This summary is based on the bill title and the available legislative actions; the full bill text, committee reports, amendments, and fiscal analyses are necessary to state precise prohibitions, definitions, exceptions, enforcement, and implementation details. For authoritative information, consult the official bill text and legislative journal entries for HB 5370 and any related committee reports.